How are scientists measuring and supporting longevity?
Today’s top tests, biomarkers and ingredients focus on living healthier, longer.
Today’s top tests, biomarkers and ingredients focus on living healthier, longer.
In this article, we will discuss the commonly used model organisms for microbiome research, and what insights they can provide.
Recently, researchers at Cleveland Clinic’s Genomic Medicine Institute published an article in Nature Aging which has caused quite a stir in the medical community and media – in the article these researchers report that an analysis of over 7 million people, spanning six years, found that those taking the Erectile dysfunction (ED) drug sildenafil (marketed as Viagra) were 69% less likely to develop Alzheimer’s disease (AD). This being said, there are some important caveats to this study – and so, although media reports on this study include lines such as “the little blue pill could soon be prescribed to tackle dementia”, more realistic implications should be the takeaway (but not less exciting!).
When asked how someone died, ‘they died of old age’ is an acceptable answer – it is given as the cause, like a heart attack, stroke, or cancer. However, unlike these other answers, aging is not classified as a disease. But should it be? This article will discuss the debate over whether aging should be considered a disease, the arguments for and against such a classification, what it would mean from a clinical standpoint, and how it would transform the pharmaceutical and nutraceutical industries.
Humans are living longer than any other time in history, but what is the quality of life during these years? This article will discuss lifespan and health: what are they, how are they different, and how are they connected?
In our most recent white paper we aim to answer the questions – What is the microbiome? How does it help or hinder health? And, what does recent research indicate?
Download our sample report to learn more about our validated platform that uses the best non-vertebrate model for longevity & healthspan studies.
Learn more about the DrugAge Database which highlights the high translational value of C. elegans as a model organism, and shows how valuable they can be as a tool for identifying novel drugs and drug targets in longevity research.
Developing an analysis strategy up front in parallel with experimental design is key to avoiding costly errors down the road.
The nematode Caenorhabditis elegans has provided remarkable insights into the biology of aging. The precisely measurable lifespan of worms has proven to be an efficient tool to assess the impact of various genetic, physiological and environmental factors on organismal aging. Lifespan assays can be labor intensive and time consuming. In this article, we will highlight the critical considerations that could make or break your lifespan assay. Our aim is to help you interpret a variety of different procedures by emphasizing the crucial considerations to ensure the success of running a lifespan assay.